The underlying drivers for GLP-1RA growth are strong
For lasting weight loss results, it is recommended to adopt a holistic approach that includes both medication and lifestyle changes
Sources Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence PMC TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial New England Journal of Medicine Lillys phase 2 retatrutide results Investor NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
Risk is highest during the initial titration phase and subsequent dose increases, particularly in vulnerable populations such as older adults or those with pre-existing conditions
Each dose escalation triggers a new 3-5 day wave of loose stools
In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumours, though this finding has not been established in humans